Save information for later
Sign Up

Learn About IgA Nephropathy

What is the definition of IgA Nephropathy?
IgA nephropathy is a kidney disorder that occurs when IgA (immunoglobulin A), a protein that helps the body fight infections, settles in the kidneys. In the early stages, IgA nephropathy has no symptoms. The first sign of this condition may be blood in the urine. End-stage kidney disease may develop. In most instances, the cause of this condition is unknown; however, certain disorders have been linked with IgA nephropathy, such as cirrhosis of the liver, celiac disease, and HIV infection. Although IgA nephropathy usually occurs in a family with no other affected members, several cases of familial IgA nephropathy have been reported. Familial IgA nephropathy is suspected to run through families in an autosomal dominant manner and is linked to genetic material on the long arm of chromosome 6 (6q22-23).
What are the alternative names for IgA Nephropathy?
  • IgA nephropathy
  • Berger disease
  • Berger's disease
  • Glomerulonephritis, IGA
  • IGAN
  • Nephritis, IGA type
Who are the top IgA Nephropathy Local Doctors?
Elite in IgA Nephropathy
Elite in IgA Nephropathy

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
Languages Spoken:
English
Offers Telehealth

Richard Lafayette is a Nephrologist in Stanford, California. Dr. Lafayette is rated as an Elite provider by MediFind in the treatment of IgA Nephropathy. His top areas of expertise are IgA Nephropathy, Glomerulonephritis, Focal Segmental Glomerulosclerosis, Chronic Kidney Disease, and Kidney Transplant.

Elite in IgA Nephropathy
Elite in IgA Nephropathy
Leicester, ENG, GB 

Jonathan Barratt practices in Leicester, United Kingdom. Mr. Barratt is rated as an Elite expert by MediFind in the treatment of IgA Nephropathy. His top areas of expertise are IgA Nephropathy, Glomerulonephritis, Chronic Kidney Disease, Focal Segmental Glomerulosclerosis, and Kidney Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in IgA Nephropathy
Elite in IgA Nephropathy
Urayasu, JP 

Hitoshi Suzuki practices in Urayasu, Japan. Mr. Suzuki is rated as an Elite expert by MediFind in the treatment of IgA Nephropathy. His top areas of expertise are IgA Nephropathy, Glomerulonephritis, Heart Failure, Angioplasty, and Kidney Transplant.

What are the latest IgA Nephropathy Clinical Trials?
An Open-Label Biomarker Study of BHV-1400 in IgA Nephropathy

Summary: The purpose of this study is to determine if BHV-1400 is a safe and tolerable treatment in participants with IgA Nephropathy (IgAN).

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Felzartamab in Adults With IgA Nephropathy (PREVAIL)

Summary: In this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). This study will focus on participants who have protein in their urine (proteinuria) as a result of damaged kidneys. The main goal of the study is to learn about the effect felzartamab has on proteinuria. The main question that researchers want to answer is: • How much d...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for IgA Nephropathy?
Albuminuria and kidney disease progression in IgA nephropathy in China.
Plasmacytoid dendritic cells modulate the production of mucosal IgA in IgA nephropathy.
Tired of the same old research?
Check Latest Advances